metoprolol has been researched along with Renal Insufficiency, Chronic in 9 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is little evidence guiding selection of nondiuretic, antihypertensive agents with a goal of lowering uric acid (SUA) and minimizing gout risk." | 9.24 | Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. ( Appel, LJ; Juraschek, SP; Miller, ER, 2017) |
| "There is little evidence guiding selection of nondiuretic, antihypertensive agents with a goal of lowering uric acid (SUA) and minimizing gout risk." | 5.24 | Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. ( Appel, LJ; Juraschek, SP; Miller, ER, 2017) |
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| " The new model is useful for estimating the risk of drug interaction in clinical practice when AST-120 is used in combination with other drugs." | 1.43 | Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs. ( Kotegawa, T; Koya, Y; Machi, Y; Namiki, N; Shobu, Y; Uchida, S, 2016) |
| "Atenolol treatment initiation was associated with lower 90-day risk of mortality than metoprolol tartrate (incidence, 0." | 1.40 | Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. ( Devereaux, PJ; Fleet, JL; Garg, AX; Jain, AK; McArthur, E; Ozair, S; Roberts, MA; Weir, MA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Schlosser, P | 1 |
| Li, Y | 1 |
| Sekula, P | 1 |
| Raffler, J | 1 |
| Grundner-Culemann, F | 1 |
| Pietzner, M | 1 |
| Cheng, Y | 1 |
| Wuttke, M | 1 |
| Steinbrenner, I | 1 |
| Schultheiss, UT | 1 |
| Kotsis, F | 1 |
| Kacprowski, T | 1 |
| Forer, L | 1 |
| Hausknecht, B | 1 |
| Ekici, AB | 1 |
| Nauck, M | 1 |
| Völker, U | 1 |
| Walz, G | 1 |
| Oefner, PJ | 1 |
| Kronenberg, F | 1 |
| Mohney, RP | 1 |
| Köttgen, M | 1 |
| Suhre, K | 1 |
| Eckardt, KU | 1 |
| Kastenmüller, G | 1 |
| Köttgen, A | 1 |
| Juraschek, SP | 1 |
| Appel, LJ | 1 |
| Miller, ER | 1 |
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Fine, JP | 1 |
| Heiss, G | 1 |
| Layton, JB | 1 |
| Flythe, JE | 1 |
| Khatir, DS | 1 |
| Pedersen, M | 1 |
| Ivarsen, P | 1 |
| Christensen, KL | 1 |
| Jespersen, B | 1 |
| Buus, NH | 1 |
| Fleet, JL | 1 |
| Weir, MA | 1 |
| McArthur, E | 1 |
| Ozair, S | 1 |
| Devereaux, PJ | 1 |
| Roberts, MA | 1 |
| Jain, AK | 1 |
| Garg, AX | 1 |
| Randhawa, SK | 1 |
| Elliott, WJ | 1 |
| Koya, Y | 1 |
| Uchida, S | 1 |
| Machi, Y | 1 |
| Shobu, Y | 1 |
| Namiki, N | 1 |
| Kotegawa, T | 1 |
| Al-Ramahi, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| African American Study of Kidney Disease and Hypertension ABPM Pilot Study[NCT00582777] | Phase 2/Phase 3 | 180 participants (Anticipated) | Interventional | 2007-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for metoprolol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Antihypertensive Agents; Biomarkers; Black or African | 2017 |
Effects of additional vasodilatory or nonvasodilatory treatment on renal function, vascular resistance and oxygenation in chronic kidney disease: a randomized clinical trial.
Topics: Amlodipine; Angiotensins; Antihypertensive Agents; Disease Progression; Glomerular Filtration Rate; | 2019 |
7 other studies available for metoprolol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.
Topics: Acetyltransferases; Alkaline Phosphatase; Biomarkers; Biotransformation; Cohort Studies; Cytochrome | 2020 |
A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Carvedilol; Cohort Studies; Female; Humans; Male; Meto | 2018 |
Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atenolol; Coh | 2014 |
Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Female; Humans; Kidney; Male; Metoprolol; Populati | 2014 |
Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.
Topics: Administration, Oral; Adsorption; Aluminum Hydroxide; Amlodipine; Aspirin; Carbon; Drug Interactions | 2016 |
Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Calcium Carbonate; Chi-Square Distribution; Die | 2012 |